CINECA IRIS Institutional Research Information System

LAMBA, SIMONA ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.479
EU - Europa 3.386
AS - Asia 2.458
SA - Sud America 245
OC - Oceania 86
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.225
CN - Cina 1.305
IT - Italia 1.133
GB - Regno Unito 342
DE - Germania 325
JP - Giappone 288
FR - Francia 275
IE - Irlanda 169
ES - Italia 155
CA - Canada 154
KR - Corea 145
PL - Polonia 144
FI - Finlandia 118
SE - Svezia 116
TR - Turchia 113
TW - Taiwan 109
UA - Ucraina 86
MX - Messico 78
DK - Danimarca 76
NL - Olanda 70
IN - India 67
HK - Hong Kong 65
AU - Australia 61
CH - Svizzera 60
PE - Perù 58
BE - Belgio 56
BR - Brasile 56
VN - Vietnam 56
IL - Israele 51
AT - Austria 49
SG - Singapore 47
RO - Romania 41
CO - Colombia 38
CL - Cile 33
CZ - Repubblica Ceca 30
TH - Thailandia 29
SA - Arabia Saudita 28
IR - Iran 26
NZ - Nuova Zelanda 25
ID - Indonesia 23
PT - Portogallo 22
AR - Argentina 21
GR - Grecia 21
EC - Ecuador 20
HU - Ungheria 19
NO - Norvegia 17
RU - Federazione Russa 17
MY - Malesia 14
JO - Giordania 12
LB - Libano 12
PH - Filippine 12
SK - Slovacchia (Repubblica Slovacca) 11
GY - Guiana 10
PS - Palestinian Territory 10
SN - Senegal 10
PR - Porto Rico 9
KZ - Kazakistan 8
MO - Macao, regione amministrativa speciale della Cina 8
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
HR - Croazia 6
NI - Nicaragua 6
EG - Egitto 5
NG - Nigeria 5
QA - Qatar 5
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
CY - Cipro 3
SI - Slovenia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
IQ - Iraq 2
MN - Mongolia 2
RS - Serbia 2
SV - El Salvador 2
TZ - Tanzania 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
EU - Europa 1
KE - Kenya 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
PA - Panama 1
SY - Repubblica araba siriana 1
Totale 10.692
Salva come PNG Salva come JPEG
Città #
Ann Arbor 806
Chandler 285
Beijing 263
Fairfield 201
Guangzhou 157
Dublin 153
Redwood City 153
Shanghai 151
Houston 147
Ashburn 128
Dearborn 124
Woodbridge 111
Milan 109
Turin 102
Cambridge 98
Seattle 97
Torino 89
Wilmington 82
Tokyo 73
Warsaw 63
New York 61
Pisa 58
Villeurbanne 55
Nyköping 53
Jacksonville 51
Wuhan 49
Fremont 46
Lima 46
Taipei 45
Lappeenranta 44
Princeton 44
Rome 43
Nanjing 40
Medford 39
Boston 37
Dundee 36
Hangzhou 36
Vienna 36
Buffalo 34
Toronto 34
Istanbul 32
Paris 32
Barcelona 30
Carrara 30
Seoul 30
San Diego 29
Ithaca 28
London 28
Stuttgart 28
Berlin 26
Brussels 26
Chengdu 26
Chicago 24
Genoa 24
Jinan 24
Munich 24
Washington 24
Dong Ket 23
Duncan 21
Zurich 21
Iowa City 20
Ottawa 20
Chongqing 19
Los Angeles 19
Toulouse 19
Bogotá 18
Santiago 18
Central District 17
Luni 17
Marcellus 17
Sydney 17
Brooklyn 16
Florence 16
Rochester 16
Zhengzhou 16
San Jose 15
Shenyang 15
Tianjin 15
Changsha 14
Madrid 14
Medellín 14
Naples 14
Xian 14
Bologna 13
Bucharest 13
Bursa 13
Central 13
Falls Church 13
Jerusalem 13
Shenzhen 13
Pittsburgh 12
San Francisco 12
Singapore 12
Changchun 11
Denver 11
Fuzhou 11
Jeddah 11
Miami 11
Norwalk 11
Oslo 11
Totale 5.393
Salva come PNG Salva come JPEG
Nome #
High-dose Vitamin C enhances cancer immunotherapy 3.942
Adaptive mutability of colorectal cancers in response to targeted therapies 1.597
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer 541
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 481
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 440
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 357
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 309
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. 226
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 216
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 212
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. 186
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 155
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. 151
Mutational profiling of kinases in glioblastoma. 146
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies 123
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer 114
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 112
Absence of AKT1 mutations in glioblastoma 108
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 106
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer 105
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 102
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 100
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer 98
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 97
AKT1 (E17K) in human solid tumours 96
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 91
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors 89
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma 85
Mutational profile of GNAQQ209 in human tumors 73
Mutational profiling of Cancer Candidate genes in Glioblastoma, Melanoma and Pancreatic Carcinoma reveals a snapshot of their genomic landscapes 70
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 70
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 62
The prognostic IDH1 ( R132 ) mutation is associated with reduced NADP (+)-dependent IDH activity in glioblastoma 61
Targeted Knock-in of the Polymorphism rs61764370 Does Not Affect KRAS Expression but Reduces let-7 Levels 61
Ras Mutations in Cancer 52
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling 45
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 30
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages 14
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells 5
Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer 3
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 3
Totale 10.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.833
article - articoli 0
book - libri 0
conference - conferenze 953
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019178 0 0 0 0 0 0 0 0 0 0 125 53
2019/2020771 41 30 40 89 57 103 100 39 64 74 82 52
2020/20212.077 57 93 203 214 173 192 254 145 183 171 125 267
2021/20222.695 273 270 286 345 180 159 195 199 207 151 234 196
2022/20232.420 159 157 200 188 151 283 237 217 257 158 246 167
2023/20241.901 229 188 217 217 198 169 164 172 74 255 18 0
Totale 10.934